Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies

Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies. (Credit: Arek Socha from Pixabay)